Precision Drug Theraputics: Risk Prediction in Pharmacoepidemiology

Lead Research Organisation: University of Strathclyde
Department Name: Inst of Pharmacy and Biomedical Sci

Abstract

Health Data Research UK (HDR UK) is an institute for health and biomedical informatics research. Part of its mission is to transform health care through the application of multidisciplinary team expertise.

This project aims to contribute to the HDR UK mission by applying advanced methodological approaches to build models which will enable outcomes to be predicted for appropriate groups of patients with distinct mechanisms of disease (cardiovascular disease, cancer) or particular responses to treatment (stratified medicine) and to support the development of precision therapeutics.

The objective of the project is to create Clinical Decision Support tools for routine use.

Technical Summary

The project will develop statistical and machine learning algorithms to analyse NHS datasets to build predictive models to support precision therapeutics focusing on the following two areas:
1) Cancer chemotherapy
2) Cardiovascular therapies

HDR UK will provide the data repositories for linkage of established patient cohorts to further phenotypic resources. This will provide deeper phenotyping and should allow more precise prediction algorithms to be developed. Advanced statistical modelling (logistic regression, least absolute shrinkage and selection operator (LASSO) regression, Bayesian modelling) and machine learning approaches (neural nets, deep learning algorithms) will be used as part of this approach. The precision and incremental value of additional datasets will be assessed as will automated approaches to optimising algorithms. Existing research in the use of Bayesian hierarchical point-mass models, based around body-systems, to detect safety signals in clinical trials may be extended for use in observational studies. This approach is designed to use the additional information given by the relationships within and between body-systems in a statistical analysis.

The outcomes of the project, in this case the prediction models, will be translated into Clinical Decision Support (CDS) tools which will promote learning health systems. User and usability experience data will be captured during CDS design and development. The output will be a prototype intervention suitable for evaluation through the MRC Complex Intervention Framework to support clinicians in making informed choices and highlighting the risks in the different possible prescribing choices.
 
Title Bayesian Hierarchical Possion Models for Mulitple Grouped Outcomes with Clustering - Simulation Study 
Description Simulation study of cluster hierarchical outcomes for bhpm (Bayesian Hierarchical Possion Models for Mulitple Grouped Outcomes with Clustering) model fitting, error estimation, and outcome detection. The dataset contains 4 simulations with varying rates. Code for generating and running the simulations is supplied. Bourne shell scripts for automating the simulations on a linux platform are supplied. 
Type Of Material Database/Collection of data 
Year Produced 2020 
Provided To Others? Yes  
URL https://pureportal.strath.ac.uk/en/datasets/c8a0433e-042a-4088-9c4b-323943f14953
 
Description CVD-COVID-UK / COVID-IMPACT Consortium 
Organisation British Heart Foundation (BHF)
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution I have worked on a number of projects associated with the CVD-COVID UK Consortium.
Collaborator Contribution In partnetship with eDRIS we curated Scottish healthcare data for use by researchers in multiple UK wide projects
Impact We have a pre-pint paper which will be submitted to a journal shortly: Dale CE, Takhar R, Carragher R, Torabi F,, Sofat R. The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale descriptive analysis of trends in medication data. medRxiv 2021.12.31.21268587; https://doi.org/10.1101/2021.12.31.21268587.
Start Year 2021
 
Description CVD-COVID-UK / COVID-IMPACT Consortium 
Organisation Health Data Research UK
Country United Kingdom 
Sector Private 
PI Contribution I have worked on a number of projects associated with the CVD-COVID UK Consortium.
Collaborator Contribution In partnetship with eDRIS we curated Scottish healthcare data for use by researchers in multiple UK wide projects
Impact We have a pre-pint paper which will be submitted to a journal shortly: Dale CE, Takhar R, Carragher R, Torabi F,, Sofat R. The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale descriptive analysis of trends in medication data. medRxiv 2021.12.31.21268587; https://doi.org/10.1101/2021.12.31.21268587.
Start Year 2021
 
Description Cancers Medicines Outcome Program 
Organisation NHS Greater Glasgow and Clyde (NHSGGC)
Country United Kingdom 
Sector Public 
PI Contribution The determination of baseline characteristics, outcomes and survival for myeloma patients.
Collaborator Contribution Data collection and analysis. Expert medical input.
Impact This is a recent collaboration for me. Outputs so far have been the determination of the baseline and survival characteristics for myeloma patients receiving pomalidomide in the West of Scotland. Myeloma results presented at British Oncology Pharmacy Association (BOPA) Annual symposium, 08-10 October 2021.
Start Year 2020
 
Description Oral anticoagulant or no treatment in patients with atrial fibrillation at moderate stroke risk: a multi-centre observational study. 
Organisation Karolinska Institute
Country Sweden 
Sector Academic/University 
PI Contribution We helped design the study. We provided the data and analysis for the Scottish section of the study. We participated in the review of the manuscript.
Collaborator Contribution Each institution provided the data and analysis for their section. Utrecht University co-ordinated the research, combined the results and produced a manuscript for review.
Impact A manuscript: "Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study" has been published in the European Heart Journal 10/03/2022.
Start Year 2020
 
Description Oral anticoagulant or no treatment in patients with atrial fibrillation at moderate stroke risk: a multi-centre observational study. 
Organisation Norwegian Institute of Public Health
Country Norway 
Sector Public 
PI Contribution We helped design the study. We provided the data and analysis for the Scottish section of the study. We participated in the review of the manuscript.
Collaborator Contribution Each institution provided the data and analysis for their section. Utrecht University co-ordinated the research, combined the results and produced a manuscript for review.
Impact A manuscript: "Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study" has been published in the European Heart Journal 10/03/2022.
Start Year 2020
 
Description Oral anticoagulant or no treatment in patients with atrial fibrillation at moderate stroke risk: a multi-centre observational study. 
Organisation University of Southern Denmark
Country Denmark 
Sector Academic/University 
PI Contribution We helped design the study. We provided the data and analysis for the Scottish section of the study. We participated in the review of the manuscript.
Collaborator Contribution Each institution provided the data and analysis for their section. Utrecht University co-ordinated the research, combined the results and produced a manuscript for review.
Impact A manuscript: "Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study" has been published in the European Heart Journal 10/03/2022.
Start Year 2020
 
Description Oral anticoagulant or no treatment in patients with atrial fibrillation at moderate stroke risk: a multi-centre observational study. 
Organisation Uppsala University
Country Sweden 
Sector Academic/University 
PI Contribution We helped design the study. We provided the data and analysis for the Scottish section of the study. We participated in the review of the manuscript.
Collaborator Contribution Each institution provided the data and analysis for their section. Utrecht University co-ordinated the research, combined the results and produced a manuscript for review.
Impact A manuscript: "Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study" has been published in the European Heart Journal 10/03/2022.
Start Year 2020
 
Description Oral anticoagulant or no treatment in patients with atrial fibrillation at moderate stroke risk: a multi-centre observational study. 
Organisation Utrecht University
Department Division of Pharmacology
Country Netherlands 
Sector Academic/University 
PI Contribution We helped design the study. We provided the data and analysis for the Scottish section of the study. We participated in the review of the manuscript.
Collaborator Contribution Each institution provided the data and analysis for their section. Utrecht University co-ordinated the research, combined the results and produced a manuscript for review.
Impact A manuscript: "Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study" has been published in the European Heart Journal 10/03/2022.
Start Year 2020
 
Description Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries 
Organisation Karolinska Institute
Country Sweden 
Sector Academic/University 
PI Contribution We provided the data and analysis for the Scottish contribution to the project.
Collaborator Contribution All other parties provided the data and analysis for their regions. Utrecht University co-ordinated the projects and authored the manuscript for review.
Impact Manuscript: Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries currently being reviewed prior to submission.
Start Year 2020
 
Description Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries 
Organisation Norwegian Institute of Public Health
Country Norway 
Sector Public 
PI Contribution We provided the data and analysis for the Scottish contribution to the project.
Collaborator Contribution All other parties provided the data and analysis for their regions. Utrecht University co-ordinated the projects and authored the manuscript for review.
Impact Manuscript: Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries currently being reviewed prior to submission.
Start Year 2020
 
Description Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries 
Organisation University of Southern Denmark
Country Denmark 
Sector Academic/University 
PI Contribution We provided the data and analysis for the Scottish contribution to the project.
Collaborator Contribution All other parties provided the data and analysis for their regions. Utrecht University co-ordinated the projects and authored the manuscript for review.
Impact Manuscript: Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries currently being reviewed prior to submission.
Start Year 2020
 
Description Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries 
Organisation Uppsala University
Country Sweden 
Sector Academic/University 
PI Contribution We provided the data and analysis for the Scottish contribution to the project.
Collaborator Contribution All other parties provided the data and analysis for their regions. Utrecht University co-ordinated the projects and authored the manuscript for review.
Impact Manuscript: Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries currently being reviewed prior to submission.
Start Year 2020
 
Description Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries 
Organisation Utrecht University
Country Netherlands 
Sector Academic/University 
PI Contribution We provided the data and analysis for the Scottish contribution to the project.
Collaborator Contribution All other parties provided the data and analysis for their regions. Utrecht University co-ordinated the projects and authored the manuscript for review.
Impact Manuscript: Stroke prevention in atrial fibrillation before and after the introduction of non-vitamin K antagonist oral anticoagulants in four Western European countries currently being reviewed prior to submission.
Start Year 2020
 
Title Bayesian Hierarchical Possion Models for Mulitple Grouped Outcomes with Clustering 
Description Bayesian methods for the detection of differences in rates of outcomes for multiple treatments for clustered observations. This software was developed for the Risk Prediction in Pharmacoepidemology project as part of a Rutherford Fund Fellowship at Health Data Research (UK), HRDUK@Scotland. 
Type Of Technology Software 
Year Produced 2019 
Impact The software has been designed for use with observational routinely collected healthcare data which would typically be analysed by time to event models such as Cox proportional hazards models. The software allows multiple related outcomes to be modelled within a single hierarchy. It has been applied to an existing study of direct oral anti-cogulants in Scotland. 
URL https://github.com/rcarragh/bhpm